Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_88bc5a3b74aa2a2a1e14c672bf37fed4 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-47 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57484 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57407 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
filingDate |
2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ab5f63e288650c078a35b153388dcf5a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_71e95ab9d451df9d88812a05eea25c21 |
publicationDate |
2019-09-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CN-110229903-A |
titleOfInvention |
PODN as a molecular marker for the diagnosis of thyroid cancer |
abstract |
The invention discloses a molecular marker-PODN for early diagnosis of thyroid cancer. The research of the present invention proves that the mRNA expression level of PODN gene in thyroid cancer patients is significantly decreased compared with the adjacent tissue. According to the existing correlation between PODN gene and thyroid cancer, a kit for diagnosing thyroid cancer can be prepared, and the kit can be widely used in clinic. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110184358-A |
priorityDate |
2019-06-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |